Register entryShortage reported
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 14
- Shortage listings
- 4
- Countries
- 0
Alert
Drug shortage listings
4| Drug | Presentation | Status | Availability | Posted / updated |
|---|---|---|---|---|
| Dexmedetomidine Hydrochloride InjectionAnesthesia | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-601-04) | Current | Available | 10 Apr 20201 Oct 2026 |
| Dexmedetomidine Hydrochloride InjectionAnesthesia | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-602-24) | Current | Available | 10 Apr 20201 Oct 2026 |
| Dexmedetomidine Hydrochloride InjectionAnesthesia | Dexmedetomidine Hydrochloride, Injection, 4 ug/1 mL (NDC 44567-603-24) | Current | Available | 10 Apr 20201 Oct 2026 |
| Dexmedetomidine Hydrochloride InjectionAnesthesia | Dexmedetomidine Hydrochloride, Injection, 100 ug/1 mL (NDC 44567-600-04) | Current | Available | 10 Apr 20201 Oct 2026 |
Exclusivity
Patents and exclusivities
14| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 8829054 | ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER, ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINEResmolol hydrochloride | product | Mar 2033 |
| 8835505 | ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER, ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINEResmolol hydrochloride | product | Mar 2033 |
| 9649296 | DEXMEDETOMIDINE HYDROCHLORIDEdexmedetomidine hydrochloride | product | Apr 2036 |
| 9717796 | DEXMEDETOMIDINE HYDROCHLORIDEdexmedetomidine hydrochloride | product | Apr 2036 |
| 10130646 | CALCIUM GLUCONATE IN SODIUM CHLORIDEcalcium gluconate | product | Jul 2037 |
| 10342813 | CALCIUM GLUCONATE IN SODIUM CHLORIDEcalcium gluconate | product | Jul 2037 |
Enquiry
Common questions
- Is HQ SPECIALTY PHARMA CORP FDA approved?
- HQ SPECIALTY PHARMA CORP holds no registered establishment of its own; it appears here on its Orange Book patents.
- Are any HQ SPECIALTY PHARMA CORP products in shortage?
- 4 presentations are currently listed in the FDA drug shortage database under HQ SPECIALTY PHARMA CORP, covering Dexmedetomidine Hydrochloride Injection.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.